ARCHIVES

Wyden Hearing On Taxol Agreements Mangles Facts In Attempt To Protect ‘Public Interest’

This article is from The Cancer Letter archive.

Vol. 17 No. 32 | August 9, 1991

Download PDF Visit The Full Archive

Related Articles

Conversation With The Cancer Letter: PanCAN CEO Denies Bill Would Undermine NCI’s Role in Directing and Funding Research

August 3, 2012

Statins Associated With Lower Risk Of High-Grade Prostate Cancer

March 25, 2011

White House Picks Harold Varmus For NCI

May 21, 2010

NCI, USSR Agree On New Collaborative Cancer Control Studies

June 20, 1975

GM Honors Blackburn, Kuhl, Phelps, Speizer, And Willett

June 8, 2001

In Brief: Wittes to Join Bristol-Myers As VP; Friedman Named Acting CTEP Director; Carl Pinsky Leaves

September 23, 1988